Alkem Laboratories Ltd.

NSE: ALKEM | BSE: 539523

Mid-range Performer

In 1 Starfolio Basket

Download real time

5344.00 109.00 (2.08%)

219.1K

NSE+BSE Volume

NSE 27 Apr, 2026 3:31 PM (IST)

CEO Resignation

Alkem Laboratories' CEO, Vikas Gupta, tenders his resignation, effective June 30 See details

Alkem Laboratories News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Alkem Laboratories from all sources in a single place.

Alkem Laboratories Ltd.

24 Apr 2026

5344.00

2.08%

Company Update

Alkem Laboratories Ltd - 539523 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure …

BSE India

Please find attached herewith intimation in respect of an order passed by Statutory Authority under the Income Tax Act, 1961

Alkem Laboratories Ltd.

24 Apr 2026

5344.00

2.08%

Alkem Labs CEO Dr. Vikas Gupta resigns; stock falls nearly 3%

Business Line

Markets reacted negatively to the announcement, with Alkem's shares on the NSE dropping 154.50 (2.80%) to 5,366 from a previous close of 5,520.50

Number of FII/FPI investors decreased from 613 to 607 in Mar 2026 qtr

Alkem Laboratories Ltd.

24 Apr 2026

5344.00

2.08%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Cessation

BSE India

Please find attached herewith intimation for Change in Key Managerial Personnel - Resignation of Chief Executive Officer

Alkem Laboratories Ltd.

13 Apr 2026

5344.00

2.08%

Company Update

Alkem Laboratories Ltd - 539523 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure …

BSE India

Please find Attached herewith Intimation for Incorporation of Wholly owned subsidiary of the Company.

Alkem Laboratories Ltd.

07 Apr 2026

5344.00

2.08%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Please find attached herewith Press release- Alkem Launches A to Z Daily, an everyday multivitamin supplement for body and mind.

Alkem Laboratories Ltd.

02 Apr 2026

5344.00

2.08%

Alkem Labs to increase investment to 1,036 crore for new unit in Ujjain

Business Standard

Alkem Laboratories Ltd on Thursday announced almost doubling of investment to up to Rs 1,036 crore for its proposed greenfield formulations manufacturing facility in Ujjain, Madhya Pradesh. The board of the directors of the company on April 2 has approved an increase in investment from up to Rs 533 crore to up to Rs 1,036 crore to be made in a phased manner for setting up of manufacturing facility in Ujjain, Alkem Laboratories Ltd said in a regulatory filing. Earlier on March 18, the company had stated that it has received allotment letter from DMIC Vikram Udyogpuri Ltd, for allotment of 30 acres land for setting up of the greenfield formulations manufacturing facility at Ujjain and the company's board had approved an investment of up to Rs 533 crore to be made in a phased manner.

Alkem Laboratories L.. has an average target of 5995.67 from 3 brokers.

Alkem Laboratories Ltd.

02 Apr 2026

5344.00

2.08%

Company Update

Alkem Laboratories Ltd - 539523 - Please Find Attached Herewith Intimation About Increase In Investment To …

BSE India

Please find attached herewith intimation about increase in investment to be made for setting up of manufacturing facility of the Company in Ujjain, Madhya Pradesh.

Alkem Laboratories Ltd.

31 Mar 2026

5344.00

2.08%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Please find attached herewith Intimation regarding change in Senior Management.

Alkem Laboratories Ltd.

30 Mar 2026

5344.00

2.08%

Company Update

Alkem Laboratories Ltd - 539523 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure …

BSE India

Please Find Attached herewith Intimation for Incorporation of Wholly Owned Subsidiary of the Company as a ''Scientific Office''.

Alkem Laboratories Ltd.

27 Mar 2026

5344.00

2.08%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

This is to inform you that Mr. Samsher Kumar Deo has been appointed as Senior Management Position in the Company effective from 27th March,2026

Is Alkem Laboratories Ltd. worth buying?

141 Votes:

Buy 79.43%

Sell 14.18%

Hold 6.38%

RESEARCH REPORTS

Neutral SEE REPORTS >

Buy SEE REPORTS >